Updates on Waldenstrom Macroglobulinemia: Does Ibrutinib Improve OS/PFS in Treatment-Naïve Disease? Is Rituximab the Best Maintenance Option? Can We Achieve CR With Zanubrutinib?
By
2nd SOHO Italian Conference
FEATURING
Alessandra Tedeschi
By
2nd SOHO Italian Conference
FEATURING
Alessandra Tedeschi
Comments 0
Login to view comments.
Click here to Login
